IVIg immunosuppression in HLA-sensitized transplant recipients
US6171585A · kind A · utility
2Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 1994 |
| Grant date | Jan 9, 2001 |
| Priority date | — |
| Expiry date | Sep 26, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are provided for transplanting a histoincompatible organ allograft in a subject, methods for enhancing organ allograft survival in a subject, methods for reducing the amount of anti-HLA alloantibodies in a transplant candidate and methods to make candidate less susceptible to rejection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.